Respiratory outcomes in preterm neonates (<32 weeks): impact of complete, partial, and absent antenatal steroid exposure

Bilal A. Paul; Ashfaq Masood; Syed B. Ahmed; Mushtaq A. Bhat; Zubair M. Tramboo; Javeed I. Bhat

doi:10.18203/2349-3291.ijcp20253305

Authors

Bilal A. Paul Department of Neonatology and Pediatrics, Sheri Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Ashfaq Masood Department of Neonatology and Pediatrics, Sheri Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Syed B. Ahmed Department of Neonatology and Pediatrics, Sheri Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Mushtaq A. Bhat Department of Neonatology and Pediatrics, Sheri Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Zubair M. Tramboo Department of Neonatology and Pediatrics, Sheri Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
Javeed I. Bhat Department of Neonatology and Pediatrics, Sheri Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20253305

Keywords:

Preterm neonates, Antenatal corticosteroids, Respiratory distress syndrome, Bronchopulmonary dysplasia, Neonatal mortality

Abstract

Background: Preterm birth is a leading cause of neonatal morbidity and mortality, with respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), and prolonged respiratory support as major complications. While antenatal corticosteroids improve respiratory outcomes, the effects of complete, partial, and absent exposure in infants <32 weeks are inconsistently reported. Aim of the study was to compare respiratory outcomes among preterm neonates <32 weeks based on complete, partial, or no antenatal corticosteroid exposure.

Methods: A prospective observational study conducted in the neonatal intensive care unit (NICU) of Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, from January 2021 to June 2025. 185 preterm neonates <32 weeks gestation were included: complete antenatal corticosteroids (ACS) (n=127), partial ACS (n=41), and no ACS (n=17). Outcomes included incidence and severity of RDS, need for surfactant therapy, need for respiratory support, BPD at 36 weeks postmenstrual age, and mortality. Statistical analysis included Chi-square, Kruskal–Wallis, and multivariate logistic regression.

Results: Complete ACS significantly reduced RDS (32.3% versus 46.3% and 58.8%), severe RDS, invasive ventilation, and surfactant use (all p<0.05). Median ventilation duration (3 versus 5 versus 7 days) and time to room air (20 versus 30 versus 50 days) were shortest with complete ACS (p<0.001). BPD (16.5% versus 22.0% versus 58.8%, p<0.001) and mortality (17.3% versus 31.7% versus 52.9%, p=0.002) were also lowest. ACS coverage, gestational age, and birth weight independently predicted outcomes.

Conclusions: Complete ACS markedly improves outcomes in preterm infants <32 weeks, underscoring the need for timely administration in high-risk pregnancies.

Metrics

Metrics Loading ...

References

Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162. DOI: https://doi.org/10.1016/S0140-6736(12)60820-4

Ohuma EO, Moller AB, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, Okwaraji YB et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet. 2023;402:1261. DOI: https://doi.org/10.1016/S0140-6736(23)00878-4

Polin RA, Fox WW, Abman SH. Fetal and Neonatal Physiology. 5th Edition. Elsevier. 2017.

Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, Te Pas A, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2022 Update. Neonatology. 2023;119(1):3-23. DOI: https://doi.org/10.1159/000528914

McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12:CD004454. DOI: https://doi.org/10.1002/14651858.CD004454.pub4

Ontela V, Dorairajan G, Bhat VB, Chinnakali P. Effect of antenatal steroids on respiratory morbidity of late preterm newborns: a randomized controlled trial. J Trop Pediatr. 2018;64(6):531-8. DOI: https://doi.org/10.1093/tropej/fmy001

Li T, Shen W, Wu F, Mao J, Liu L, Chang Y, et al. Antenatal corticosteroids is associated with better postnatal growth outcomes of very preterm infants: A national multicenter cohort study in China. Front Pediatr. 2023;10:1086920. DOI: https://doi.org/10.3389/fped.2022.1086920

Jobe AH, Goldenberg RL. Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. Am J Obstet Gynecol. 2018;219(1):62-74.

Zullo F, Gulersen M, Di Mascio D, Roth SC, Logue TC, Rizzo G, et al. Antenatal corticosteroids for patients at risk of late preterm birth: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2025;7(8):101709. DOI: https://doi.org/10.1016/j.ajogmf.2025.101709

Sultana S, Bruinsma F, Fisher Z, Homer CSE, Vogel JP. Long-term outcomes of antenatal corticosteroids for preterm birth: An overview of systematic reviews. PLOS Glob Public Health. 2025;5(5):e0004575. DOI: https://doi.org/10.1371/journal.pgph.0004575

World Health Organization. WHO recommendations on interventions to improve preterm birth outcomes. 2022. Available at: https://www.who.int/ publications/i/item/9789241508988. Accessed on 12 June 2025.

Socha PM, Harper S, Strumpf E, Murphy KE, Hutcheon JA. Antenatal corticosteroids and newborn respiratory outcomes in twins: A secondary analysis. BJOG. 2024;131(8):1064-71. DOI: https://doi.org/10.1111/1471-0528.17754

Warren JB, Anderson JM. Newborn respiratory disorders. Pediatr Rev. 2010;31(12):487-95. DOI: https://doi.org/10.1542/pir.31.12.487

Pramanik AK, Rangaswamy N, Gates T. Neonatal respiratory distress: a practical approach to its diagnosis and management. Pediatr Clin North Am. 2015;62(2):453-69. DOI: https://doi.org/10.1016/j.pcl.2014.11.008

Wondie WT, Legesse BT, Mekonnen GB, Degaga GT, Zemariam AB, Gedefaw GD, et al. Incidence and predictors of respiratory distress syndrome among low birth weight neonates in the first seven days in Northwest Ethiopia Comprehensive Specialized Hospitals, 2023: A retrospective follow-up study. BMJ Open. 2023;13(11):e079063. DOI: https://doi.org/10.1136/bmjopen-2023-079063

Liu SY, Yang HI, Chen CY, Chou HC, Hsieh WS, Tsou KI, et al. The gestational effect of antenatal corticosteroids on respiratory distress syndrome in very low birth weight infants: A population-based study. J Formosan Med Assoc. 2020;119:8. DOI: https://doi.org/10.1016/j.jfma.2019.11.002

Jobe AH, Goldenberg RL. Antenatal corticosteroids: An assessment of anticipated benefits and potential risks. Am J Obstet Gynecol. 2018;219(1):62-74. DOI: https://doi.org/10.1016/j.ajog.2018.04.007

Yang T, Shen Q, Wang S, Dong T, Liang L, Xu F, et al. Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study. BMC Pediatr. 2022;22:200. DOI: https://doi.org/10.1186/s12887-022-03273-7

Moreira A, Noronha M, Joy J, Bierwirth N, Tarriela A, Naqvi A, et al. Rates of bronchopulmonary dysplasia in very low birth weight neonates: a systematic review and meta-analysis. Respir Res. 2024;25:219. DOI: https://doi.org/10.1186/s12931-024-02850-x

Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM, Wapner RJ, et al. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. Am J Obstet Gynecol. 2016;215(1):103.e1-e14.

Bulimba M, Cosmas J, Abdallah Y, Massawe A, Manji K. Early outcomes of preterm neonates with respiratory distress syndrome admitted at Muhimbili National Hospital, a prospective study. BMC Pediatr. 2022;22:731. DOI: https://doi.org/10.1186/s12887-022-03731-2

Been JV, Rours IG, Kornelisse RF, Jonkers F, de Krijger RR, Zimmermann LJ. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr. 2010;156(1):10-5. DOI: https://doi.org/10.1016/j.jpeds.2009.07.044

Bental Y, Reichman B, Shiff Y, Weisbrod M, Boyko V, Lerner-Geva L, et al. Impact of Maternal Diabetes Mellitus on Mortality and Morbidity of Preterm Infants (24–33 Weeks' Gestation). Pediatrics. 2011;128(4). DOI: https://doi.org/10.1542/peds.2010-3443

Rocha de Moura MD, Margotto PR, Nascimento Costa K, Carvalho Garbi Novaes MR. Hypertension induced by pregnancy and neonatal outcome: Results from a retrospective cohort study in preterm under 34 weeks. PLoS One. 2021;16(8):e0255783. DOI: https://doi.org/10.1371/journal.pone.0255783